Henrique Borges da Silva

8PUBLICATIONS
72CO-AUTHORS
Tumour immunologyLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 23, 2026
PD-1 regulates latent effector differentiation of thymic cytotoxic CD8+ T cells.

|Mar 27, 2026
TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris.

Alyssa Stockard, Zachary Leibovit-Reiben, Bowen Hu

|Jan 21, 2026
Regulatory T-cell Sensing of Extracellular ATP via P2RX7 Promotes Their Accumulation and Suppression and Drives Lung Tumor Growth.

Igor Santiago-Carvalho, Ronaldo Francisco, Bruna Gois Macedo

|Aug 18, 2025
A Dual Role for NKG7 in T-cell Cytotoxicity and Longevity.

Haidong Dong, Hyoungjun Ham, Whitney Barham

|Dec 08, 2023
CD8+ T Cells Keep Their (K+)urrency for Function.

Alma Banuelos, Henrique Borges da Silva

|May 19, 2022
P2RX7 Enhances Tumor Control by CD8+ T Cells in Adoptive Cell Therapy.

Kelsey M Wanhainen, Changwei Peng, Maggie H Zhou

Pageof 2

Frequent Collaborators

2 joint publications

Trupti Vardam-Kaur

2 joint publications

Fabrice Lucien-Matteoni

2 joint publications

Changwei Peng

2 joint publications

Stephen C Jameson